Schedule 13G ownership disclosure

Tarsus Pharmaceuticals Inc

Common Stock, par value $0.0001 per share · CUSIP: 87650L103

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TANG CAPITAL MANAGEMENT, LLC

    Shares: 2,454,797.00 · Class: 5.90%

  • KEVIN TANG

    Shares: 2,454,797.00 · Class: 5.90%

  • TANG CAPITAL PARTNERS, LP

    Shares: 2,334,439.00 · Class: 5.61%

  • TANG CAPITAL PARTNERS INTERNATIONAL, LP

    Shares: 62,358.00 · Class: 0.15%

  • TANG CAPITAL PARTNERS III, INC

    Shares: 43,500.00 · Class: 0.10%

  • TANG CAPITAL PARTNERS IV, INC

    Shares: 14,500.00 · Class: 0.04%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-007881
Form type
SCHEDULE 13G/A
Filer
TANG CAPITAL MANAGEMENT LLC
CIK
CIK 1232621
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub